All ArticlesBook ChaptersTotal














Current, 2018130


In press, 2017/2018 




Publications, 2018:

  1. Gupta AK, Vlahovic T, Foley KA, Lowe NG, Turner R, Brown M, Hall S. In Vitro Efficacy of Tavaborole Topical Solution, 5% after Penetration through Nail Polish on Ex Vivo Human Fingernails. Journal of Dermatological Treatment 2018 Jan 10:1-4. [epub ahead of print]. (Co-author)
  2. Gupta AK, Mays R, Abramovits W, Vincent KD. Odomzo (Sonidegib). SkinMed 2018;16(1):47-50. (Principal Author)
  3. Shemer A, Gupta AK, Babaev M, Barzilai A, Farhi R, Daniel CR. A retrospective study comparing K101nail solution as a monotherapy and in combination with oral terbinafine or itraconazole for the treatment of toenail onychomycosis. Skin Appendage Disorders 2018;4:166-170. (Co-author)
  4. Gupta AK, Mays R. The impact of onychomycosis on quality of life: A systematic review of the available literature. Skin Appendage Disorder 2018. [Epub ahead of print]. (Principal Author)
  5. Markinson B, Ghannoum M, Winter T, Rycerz A, Rock F, Gupta AK. Examining the benefits of the boron-based mechanism of action and physiochemical properties of tavaborole in the treatment of onychomycosis. Journal of the American Podiatric Medical Association 2018. [Epub ahead of print]. (Co-author)
  6. Gupta AK, Versteeg SG. The Role of Shoe and Sock Sanitization in the Management of Superficial Fungal Infections of the Feet. Journal of the American Podiatric Medical Assoication 2018 Mar 9. [Epub ahead of print]. (Principal Author)
  7. Gupta, A. K., Versteeg, S. G., & Shear, N. H. (2018). Common drug-drug interactions in antifungal treatments for superficial fungal infections. Expert Opinion on Drug Metabolism & Toxicology, 14(4), 387-398. doi:10.1080/17425255.2018.1461834
  8. Gupta, A. K., & Foley, K. A. (2018). The role of biofilms in onychomycosis. Giornale Italiano Di Dermatologia E Venereologia. doi:10.23736/S0392-0488.18.06001-7
  9. Gupta, A. K., Carviel, J., & Shear, N. H. (2017). Onychomycosis and Chronic Fungal Disease: Exploiting a Commensal Disguise to Stage a Covert Invasion. Journal of Cutaneous Medicine and Surgery, 22(3), 318-322. doi:10.1177/1203475417745827
  10. Gupta A. K., Versteeg S. G., Abramovits W., Vincent K.D.. Bavencio® (Avelumab)-A Newly Approved Anti-PD-L1 IgG1 Antibody. Skinmed. 2018;16(3):183-187.
  11. Gupta, M. A., & Gupta, A. K. (2018). Psoriasis Is Associated With a Higher Prevalence of Obstructive Sleep Apnea and Restless Legs Syndrome: A Possible Indication of Autonomic Activation in Psoriasis. Journal of Clinical Sleep Medicine, 14(06), 1085-1085. doi:10.5664/jcsm.7194
  12. Gupta, A. K., Mays, R. R., Versteeg, S. G., Shear, N. H., & Friedlander, S. F. (2018). Onychomycosis in children: Safety and efficacy of antifungal agents. Pediatric Dermatology. doi:10.1111/pde.13561
  13. Gupta, A. K., Versteeg, S. G., & Shear, N. H. (2018). A Practical Application of Onychomycosis Cure – Combining Patient, Physician and Regulatory Body Perspectives. Journal of the European Academy of Dermatology and Venereology. doi:10.1111/jdv.15181